These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9519615)

  • 21. A recurrent case of BT leprosy with widely spread skin lesions showing a histopathology of indeterminate group after 4.5-years irregular treatment, Bangladesh.
    Ishida Y; Ozaki M; Picorini L; Guglielmelli E
    Nihon Hansenbyo Gakkai Zasshi; 1999 Nov; 68(3):195-9. PubMed ID: 10659615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report of workshop on chemotherapy.
    Grosset JH; Franzblau S
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):595-6. PubMed ID: 10347587
    [No Abstract]   [Full Text] [Related]  

  • 23. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and histopathological activity in paucibacillary leprosy patients after fixed-duration multidrug therapy.
    Ebenezer GJ; Suneetha S; Arunthathi S
    Lepr Rev; 1997 Sep; 68(3):218-24. PubMed ID: 9364822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of leprosy patients with single lesions to MDT.
    Katoch K; Natrajan M; Yadav VS; Bhatia AS
    Acta Leprol; 1995; 9(3):133-7. PubMed ID: 7631584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapsone induced methaemoglobinaemia.
    Diwan SK; Sharma AK; Jain AP; Gupta OP; Jajoo UN
    Indian J Lepr; 1991; 63(1):103-5. PubMed ID: 1919080
    [No Abstract]   [Full Text] [Related]  

  • 28. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
    Ghorpade A
    Lepr Rev; 2005 Jun; 76(2):182-3. PubMed ID: 16038255
    [No Abstract]   [Full Text] [Related]  

  • 31. Involvement of lips and gums in a borderline tuberculoid leprosy patient.
    Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK
    Indian J Lepr; 1996; 68(4):367-70. PubMed ID: 9001905
    [No Abstract]   [Full Text] [Related]  

  • 32. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic changes in a tibial nerve with surviving M. leprae in a healed tuberculoid leprosy patient.
    Job CK; Baskaran B; Jayakumar J; Aschhoff M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):90-4. PubMed ID: 9207758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 36. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract]   [Full Text] [Related]  

  • 37. Borderline-tuberculoid relapse in lepromatous leprosy.
    Girdhar BK; Girdhar A; Chauhan SL; Malaviya GN; Husain S; Mukherjee A
    Lepr Rev; 1993 Jun; 64(2):157-63. PubMed ID: 8341119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
    Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
    Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A papulosquamous eruption in a 12-year-old cambodian boy.
    Rabinowitz LG; Yuengel C; Honig PJ; Solomon AR
    Pediatr Dermatol; 1989 Jun; 6(2):152-4. PubMed ID: 2748476
    [No Abstract]   [Full Text] [Related]  

  • 40. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
    Waters MF
    Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.